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N ORTH American blastomycosis (Gilchrist’s disease) is a granulomatous, infectious disease caused by the fungus, Blastomyces dermatitidis (Gilchrist 
and Stokes, 1898). The malady, in its cutaneous form, was first described by 
Gilchrist’ in 1894. A few years later, together with Stokes, he was able to iso- 
late and culture the causative organism which he designated as B. dermatitibis.23 
The first description of the disease in its systemic form was made by Walker and 
Montgomery* in 1902. 
The first reports by Gilchrist were followed by an era of confusion during 
which the disease was confounded with other entities, particularly cryptococ- 
cosis and candidiasis, all caused by morphologically similar budding organisms. 
Nineteen new names were suggested for the causative fungus. During the last 
two decades, however, a clearer picture of the disease process has emerged, 
particularly as a result of studies by the Duke Medical School group, headed by 
Smith, Martin, and Conant. Numerous clinical and laboratory reports have 
contributed significantly to a fuller understanding of the disease, but there are 
still some fundamental questions to be answered. Excellent review articles on 
North American blastomycosis are available.5-1* 
GEOGRAPHICAL DISTRIBKTION 
Martin and Smiths found in 1939 that 98 per cent of 340 proved cases of 
blastomycosis had the origin of their disease within the United States. Of the 
two cases originating elsewhere, one was from Canadalg and the other from 
England.*O Presumptive cases were reported from the Philippines, Egypt, and 
Russia, and inadequately described cases from Canada, Puerto Rico, Costa Rica, 
Russia, England, China, South America, France, and Mexico. 
The majority of patients who develop blastomycosis in the United States 
come from the Southeastern and the Midwestern states. Sporadic cases have 
been reported from all states. Schwarz and Goldman,*l in a recent questionnaire 
survey sent to 1,569 dermatologists and 403 chest surgeons throughout the United 
States, had reported to them 101 cases of North American blastomycosis diag- 
nosed and/or treated during the first 6 months of 1953. They considered the 
disease to be common throughout the United States. The presence of blasto- 
mycosis in Canada has been confirmed beyond doubt by a number of relatively 
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recent reports. 11f22-26 On the other hand, acceptable evidence for its indigenous 
occurrence in Mexico is still lacking. Martinez-Baezz7 proved an infection by 
B. dermatitidis in a Mexican farmer with demonstration of the organism. His 
claim that the infection in this patient was native to Mexico, however, was 
made less tenable by the fact that the patient worked as a migratory worker for 
8 months in California 4 years prior to the onset of clinical symptoms. 
Case reports from countries outside the North American continent appear 
from time to time in the literature. With an increasing general interest in and 
knowledge of medical mycology, more physicians are aware of the possibility 
of the occurrence of North American blastomycosis in their own countries. 
Proved or presumptively proved cases have recently been reported from India,28s29 
Spain, 3o Germany, 31 Hungary,32 Tunisia,33v34 Venezuela,36 Italy,36 and Australia.37 
Modern facilities for travel, affording greater opportunities for individuals from 
endemic areas to develop disease in other parts of the world, complicate the 
situation, as exemplified by case reports of North American blastomycosis among 
U. S. Armed Forces personnel at foreign stations in France,38 Okinawa,ls and 
and Japan.40 
EPIDEMIOLOGY 
The precise mode of infection is not yet fully known. It is generally pre- 
sumed to be exogenous, with the infective saprophytic form of the organism 
existing in nature. Unlike Coccidioides immitis, Histoplasma capsulatum, Cypt- 
ococcus neoformans, and Sporotrichum schenckii, Blustomyces dermatitidis has not 
been indubitably isolated from nature. Stober6 claimed the isolation of an or- 
ganism similar to B. dermatitidis from a rotting wooden plank in the home of 
one of his patients but this has not been confirmed. Nonetheless, the soil is 
strongly suspected as the natural reservoir of the organism. Emmons”’ success- 
fully cultured B. dermatitidis in sterilized soil in the laboratory. 
The occurrence of natural infection in dogs42-45 and horses46 suggests the 
existence of animal reservoirs. The organism has not as yet been isolated from 
wild animals. With the latest report of Newberne, Neal, and Heath,‘” a total 
of 30 cases of canine North American blastomycosis have been described in the 
literature. Apparently the disease pattern in dogs is similar to that in man. 
Pulmonary and cutaneous involvement were the most salient findings. The 
sole report of infection in a horse dealt with involvement of the udder of a mare 
proved by histopathologic sections. 
The manner of transmission of the disease has remained a provocative prob- 
lem. The infectivity of B. dermatitidis (Figs. 1 and 2) has been proved beyond 
any reasonable doubt by successful animal inoculation with either the mycelial 
or yeast phase of the organism.47-4g Lesions on the chorioallantoic membrane 
of the chick embryo have been produced with the yeast phase.50 Open skin 
lesions and body secretions or exudates, such as sputum and pus that gain access 
to the outside, teem with the tissue forms of the organism and provide excellent 
opportunities for contagion. Yet no direct natural transmission from man to 
man has been acceptably proved. A few, isolated cases of accidental mechani- 
cal inoculation through a break in the skin have been reported in laboratory 
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Fig. I.-BZastomyces dematitidis, yeast phase on blood agar. incubated at 37’ C. showing single 
budding of the yeast cells or organisms shortly after budding has occurred. Occasionally single abortive 
hyphae may be seen extending from the yeast cells in a tubelike manner. (x450; reduced x.) 
Fig. Z.-Blastomyces dermatitidis in tissue showing budding, double-refractive cellular walls and 
granulomatous infiltrate. The yeast cells are similar to Fig. 1 or to those seen here when a direct mount 
is made from pus, from the border of a granulomatous lesion or from an abscess. except for the abundance 
of associated polymorphonuclear cells. (~1,500; reduced U.) 
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Fig. 3.-A typical granulomatous lesion of the skin due to North American blastomycosis. The 
border is raised, verrucuous. and sharply limited. Tiny abscesses make up this border and pressure on 
them with a glass slide emits pus which allows direct examination and early diagnosis by identifying the 
single budding organisms. The center shows various degrees of scarring depending on the duration of 
the lesion. 
Fig. 4.-An abscess due to North American blastomycosis arising from the bony sternum and 
following a blastomycotic pneumonia by some weeks. Later other lesions appeared of the granulomatous 
as well as the abscess type. 
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workers and pathologists 13~61,62 handling cultures or infected clinical material. 
Schwarz and Baum53 did not encounter a Blastomycin skin test reactor among 
58 hospital workers and 48 home contacts in close association with patients 
having active disease. He opined that B. dermatitidis possesses a low index of 
contagiousness. 
The skin and lungs are looked upon as the most probable entry of the in- 
fection. Appearance of initial skin lesions (Fig. 3 ) have been preceded by skin 
injury from thistles, thorns, slivers, nails, cinders, clams, and dog bites. This 
antecedent trauma has been regarded as a predisposing factor. As a result of 
their review of 60 cases, Schwarz and BaumnJ4 proposed a revolutionary concept 
to which we also subscribe: that practically all cases of North American blasto- 
mycosis are pulmonary in origin, including most cases hitherto regarded as pri- 
marily cutaneous.(Fig 4.) Consequent to this thesis that the disease is essen- 
tially a pulmonary infection, a parallelism between the disease pattern of North 
Pig. 5.-Typical North American blastomycosis with scarring. atrophy, activity, and healing. The 
“centrifugal cheracter of growth” of the granulomatous lesions is well illustrated. 
American blastomycosis and those of coccidioidomycosis and histoplasmosis was 
drawn.55*56 Studies on the two latter mycoses have proved the occurrence of 
two clinical forms-the frequent, benign, primary type and the rare, generalized, 
fatal form (Figs. 5 and 6). Primary infection is usually by inhalation of infec- 
tive spores. If the evolution of the epidemiologic knowledge on North American 
blastomycosis were to follow that of coccidioidomycosis and histoplasmosis, it 
is essentially still at the stage where only the rare, fatal, disseminated disease 
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is known for certain. Coccidioidomycosis and histoplasmosis were recongized 
in this form long before the discoveries of the mild primary infections. In an 
attempt to demonstrate the existence of a prevalent benign North American 
blastomycosis, Furcolow and associates55 conducted a skin test survey with 
tuberculin, Histoplasmin, and Blastomycin among 7,194 school children ill Ham- 
ilton County., Ohio. ?;o supporting evidence was obtained. The 12 per cent 
positive reactions to Blastomycin were regarded as cross reactions to Histoplas- 
min. OnI>, one child was a Blastomycin reactor with a negative Histoplasmin 
reaction. The possibility of the occurrence of widespread, mild infections can- 
not be dismissed on the strength of negative results of skin test surveys alone. 
Subclilrical and spontaneously healirrg cases of North American blastomycosis 
have been reported.‘j,17J7 A more significant development is a report oi the 
appenrance of the disease in ~1 epidemic form. ISoiiofYg reported 23 cases of 
acute pulmorlnry. blastonly-cosis among the I’. S. lirm>. personnel ill Okinawa. 
Fig. 6.-Chest of A. W. (Table I) showing both right and left upper lobe involvement with North 
American blastomycosis. His chest cleared with some scarring after 3.0 om. of stilbamidine methionate 
and he has remained free of the disease since 4 years and 8 months. He is now alleged to have far- 
advanced tuberculosis of the lungs. (From Curtis and Harrell. A. St. A. Arch. Dermat. & Syph. 66:876. 
1952.) 
but unfortunately, his claims of demonstration of B. dermatitidis in the sputum 
and urine were not authenticated by cultures. A verified epidemic was observed 
by Smith and his associatess7 in Grifton, Pitt County, Xorth Carolina. The 
sudden appearance of 10 pulmonary cases in the locality provided an excellent 
opportunity for epidemiologic investigations. A survey. of the town population 
revealed a number of individuals with positive Blastomycin and negative Histo- 
plasmin skin tests. The source of infection, however, was not traced. 
410 CURTIS AND BOCOUO _l, (‘hron. Dis. April, 1957 
C‘LINIC’.\I, FE.-\TL:KI<S 
/lge.-The infection may appear in an)- age group. The >roungest recorded 
patient with proved North American blastom>.cosis ~YIS 5 months old.57 Kunkel 
and his co11eagues15 and Sutliff, Kyle, and Hobson’6 each had an X4-year-old 
patient in their own series. Most cases, however, occur bet\veen the ages of 
30 and 50 years and the average age of incidence falls within the fourth decade 
of life. 
Sex.-The disease is definitely more common in men thall in women. The 
reported ratio of men to women ranges from 4.3:1 to 15:l. The reason for 
this sex distribution is presumed to be the greater exposure of men to infection 
by reason of their occupations and other activities. 
Race.-No race is immune. The racial distributions in the different reported 
series of cases probably mirror the normal proportions of the races in the genera1 
population of the given locality. 
Occupation.-Many authors regard North American blastomycosis as a 
disease of the poorer working class, who have more exposure to dust, soil, wood, 
and vegetation. However, no special occupational relationships can be definitely 
claimed for the disease. 
Signs and Symptoms.-Since Gilchrist’s first report and the demonstration 
a few years later by Walker and Montgomery- of systemic involvement, North 
American blastomycosis has been classically divided into the localized cutaneous 
and the disseminated forms. The two types are divergent in clinical course, 
prognosis, and response to therapy and were thought to be due to different portals 
of the infection. The studies of Schwarz and 13aumL3J4 and \qYson and his 
associates5” change this older concept and align blastomycosis more closely 
with coccidioidomycosis. 
Cutaneous Form.-The skin lesion usually first appears as an innocuous- 
looking papulopustule on some exposed area of the body, most frequently the 
face, wrists, hands, ankles, and feet (Fig. 7). The scalp, palms, soles, and 
mucous membranes are generally not affected. No portion of the body surface, 
however, may be considered absolutely exempt. The initial lesion enlarges 
slowly and may take months, even years, to develop into a fullblown, verrucous, 
ulcerative granuloma. A typical lesion is elevated and crusted. Upon removal 
of the crusts, surface bleeding is easily induced. The surface is wartlike with 
irregular papillary elevations bathed in a seropurulent discharge. The most 
characteristic feature is the border which is elevated, sloped abruptly into, and 
sharply delineated from, the adjacent normal skin, violaceous in color, and pin- 
pointed with miliary abscesses. The lesion extends peripherally and as it in- 
creases in size, the central portions tend to heal with formation of soft, thin, 
atrophic scars. This central scar may still exhibit miliary abscesses which may 
act as foci of recurrences. 
The lesions may be single or multiple. If multiple, they often are in close 
proximity to each other, but may be remote from one another. They are arci- 
form in configuration, and coalesced lesions present serpiginous contours. The 
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USI ual size is from 3 to 4 inches in width, but may attain surprising dimensions 
UP to 12 inches, involving the trunk or whole extremities. The regional lymphat- 






Fig. 7.-A patient with North American blastomycosis treated by curette and cautery followed by 
ctional roentgen ray therapy totaling 480r in air. Since most North American blastomycosis is a 
;temic disease, this form of therapy is rarely curative although it was in this instance. 
Subjective symptoms are relatively mild, or even absent, and the general 
alth of the patient is unimpaired except in the presence of secondary bacterial 
Cections. The clinical course is marked by chronicity with long periods of 
missions and recrudescences. 
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Contrary to prevailing opinion, Schwarz and Baum13J6 considered the vast 
majority of the skin lesions described above as secondary to a healed or undis- 
covered primary focus in the lungs. This conception is gaining more propo- 
nents.15s52 Wilson and associates52 suggest, and we concur in the opinion, that 
cutaneous North American blastomycosis is a rare, but distinct clinical entity, 
represented so far only by 4 proved cases of definite cutaneous inoculation of 
Fig. 3-A patient with North American blastomycosis of the wrist, ankle, back. and lungs treated 
with 3.0 Gm. of stilbamidine (A. W.. Table I) who rapidly recovered and 4 years and 8 months later 
had no evidence of recurrence. The wrist lesion before treatment is typical of the disease. The scarring 
following treatment in the second photograph is also typical. One should remember that the lungs or 
other organs may aleo scar. Neither stilbamidine nor 2-hydroxystilbemidine give a satisfactory amount 
of “cure” in 8ystemfc North American bltutomycoais. 
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the organism with later chancre formation and regional lymphatic involvement. 
In tuberculosis, syphilis, yaws, sporotrichosis, coccidioidomycosis, and cat-scratch 
fever such a chancriform syndrome is expected. 
Systemic Form.-This can involve any organ of the body but probably 
begins in the pulmonary tract most frequently. The presenting signs and symp- 
toms depend upon the organ or organs affected and the extent of involvement. 
There is no clinical syndrome characteristic of the systemic disease, the clinical 
picture being that of any chronic infection with suppuration or fibrosis of the 
different organs. The tissues most frequently involved are the lungs, skin, sub- 
cutaneous tissues, and bones. The least commonly affected is the gastrointes- 
tinal tract. Many patients, especially in the advanced stages of the disease, 
demonstrate involvement of multiple organ systems. 
The onset is frequently associated with respiratory symptoms of cough, 
productive sputum, hemoptysis such as may be found in other lung infections, 
whether bacterial, viral, or rickettsial. It usually begins insidiously, but in certain 
instances it may be an acute and fulminant35*59e60 and blastomycotic pneumonia. 
The symptoms consist of chills, fever, productive cough, hemoptysis, chest pain, 
loss of weight, night sweats, and dyspnea. These may be transient and so mild 
as to be missed by the patient, but they may progress to dominate the clinical 
picture, which is so easily mistaken for pulmonary tuberculosis, carcinoma, or 
abscess. The infection may even assume a miliary form. The mediastinum and 
the pleura may be involved and the formation of sinuses through the chest wall 
may occur. The physical signs depend -upon the nature of the lesion and are 
often those of consolidation with fullness, increased vocal fremitus, decreased 
breath sounds, and rgles. Progressive cases eventually acquire the appearance 
of any chronic, generalized, debilitating infection with inanition, anemia, and 
extreme loss of weight and strength. 
With progression, the disease disseminates from the pulmonary focus. Dis- 
semination may happen even when the primary lesion shows a tendency to in- 
volute, as demonstrated by Schwarz and Baum.13 In this case, the patient first 
seeks medical care for complaints referable to the organs secondarily affected 
via hemotogenous spread. The pulmonary focus may escape clinical recogni- 
tion and be discovered only on autopsy or by a chance culture of the sputum in 
the face of negative x-rays. 
In a number of instances, secondary involvement of the skin appears as 
the first sign of systemic disease. The lesions develop in unexposed parts of the 
body, like the trunk, as painful, deep subcutaneous nodules. These are actually 
abscesses with a marked tendency to break through the skin and assume the 
characteristics of the lesions described as primary cutaneous. 
Involvement of the skeletal system is not uncommon. Martin and Smith,g 
Reeves and Pedersen, 61 Cherniss and Waisbren,l* and Kunkel and associates15 
found the incidence of osseous and arthritic involvement in their own series SO, 
47, 53, and 31 per cent, respectively. The symptoms, mainly pain and loss of 
function, are those of localized or diffuse osteomyelitis or periostitis and septic 
arthritis. In 63 cases reviewed by Jones and Martin,62 13 patients complained 
initially of arthritic pains in the back or one of the extremities. The ribs, verte- 
brae and skull bones, and the intervertebral knee, and elbow joints are more 
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commonly invaded. Invasion is attained either by direct extension or hemato- 
genous metastasis. Blastomycosis of the vertebral axis simulates spinal tuber- 
culosis with extensive bone destruction, marked narrowing of the disc space, 
vertebral body collapse, and associated paravertebral infection that may be 
manifested clinically as a psoas abscess.‘j3 In the long bones, the disease process 
tends to involve the epiphyses and extend directly to the adjacent joints. 
Involvement of other organs is less frequently encountered. Cases affect- 
ing the genitourinary tract were reviewed by Moore and Halpern,64 and Schwarz 
and Baum.13 Symptoms listed were pyuria, hematuria, dysuria, prostatic en- 
largement, dribbling, and urinary retention. The female genital organs are also 
involved, though rarely.65 Noojin and PraytoF recently recorded a patient 
who developed systemic blastomycosis during the second trimester of her preg- 
nancy. A normal child was born. 
Blastomycosis of the central nervous system is rather uncommon.g~13 De- 
pending upon the nature and location of the lesions, localizing symptoms of 
single or multiple abscesses in the brain or the spinal cord and manifestations 
of focal or diffuse meningitis are obtained. 
Other seats of infection occasionally described are the el.es,67-63 larynx,15~7’~72 
gastrointestinal tract, adrenals, and thyroid. 
Roentgenography.-Although sometimes a blastomycotic process may be sus- 
pected from a roentgenogram, there is no single diagnostic feature in the roent- 
genographic appearance of the disease. The pulmonary picture varies consid- 
erably from acute bilateral, massive, pneumonic consolidations to the small 
fibrotic, strandlike lesions of the quiescent stage.11~‘5,1X*73-76 Other lesions de- 
scribed are small patchy pneumonitis, lobular consolidation, mass granulomas 
located near the hilum and projecting into the lung fields with irregular out- 
lines like neoplasms, “coin” lesions, lobar atelectasis, pleural thickening with or 
without effusion, small infrequent cavitations with thin walls and hazy outlines, 
and miliary shadows. Hilar and mediastinal lymphadenopathy with or without 
parenchymal involvement is frequent. The roentgenographic findings are usu- 
ally mistakenly diagnosed as pulmonary tuberculosis or neoplasm. The other 
pulmonary conditions considered for differential diagnosis are acute pneumonias, 
lymphoblastoma, sarcoid, and pneumoconiosis. We have also seen pulmonary 
symptoms, productive and slightly bloody sputum, and a positive culture in 
the face of negative anteroposterior, lateral x-ray films, and a negative bron- 
choscophic examination. 
When systemic disease is suspected, roentgenographic examination of the 
skeletal system is advisable. The picture of osseous involvement is, like the 
pulmonary, nonspecific.73,77*78 The appearance is pre-eminently that of bone 
destruction with little or no proliferative reaction or new bone formation. The 
areas are punched out with sharp delineation from the adjacent normal bone. 
The lesions, however, are less cystlike than those occurring in coccidioidomy- 
cosis. In the long bones, these areas are located frequently at or near the epiphys- 
eal lines and the plates may reveal any associated joint involvement. Extensive 
destruction of the vertebral bodies causes collapse with compression of the spinal 
cord. A bulging of the psoas shadow suggestive of the presence of a psoas abscess 
may be present. 
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Roentgenographically, blastomycosis of the bone may be confused with 
tuberculosis, sarcoma, coccidioidomycosis, actinomycosis, syphilis, myeloma, and 
bone cysts. 
Clinical Laboratory Examinations.--The findings are those of infection. 
There is leukocytosis and neutrophilia, particularly in the presence of secondary 
bacterial infection. The erythrocyte sedimentation rate is increased. When 
the disease is sufficiently long-standing, hypochromic anemia develops. Blood 
cultures are very rarely positive, even though Schwarz and Baum13 in their histo- 
pathologic examinations were able repeatedly to demonstrate the organisms in 
the blood vessels of even uninvolved organs. 
P.\THOLOGY 
Pathologically, North American blastomycosis is a suppurative granuloma 
with a very close resemblance to tuberculosis. The gross appearance of the skin 
lesions and the tubercle-like nodules and abscesses in soft tissues and visceral 
organs is typical of the disease. The pulmonary lesions vary. There may be 
focal or diffuse pneumonic consolidation, formation of single or multiple abscesses, 
and miliary distribution of small tubercle-like nodules. Cavities are claimed to be 
infrequent a;td usually small, although dimensions up to 7 cm. in diameter ma) 
be attained.75~7g~80 Schwarz and Baum13 encountered a relatively high incidence 
of adhesive pleuritis, endobronchial lesions, and regional lymphadenopathq-. 
The!, repeatedly found evidences of scarring and healing. 
The bone lesions are essentially destructive in nature, with formation of 
abscesses, separation of sequestra, and development of chronic discharging sinuses 
through the overlying tissues and skin. 
Dissemination apparently occurs through the lymphatic and hemntogenous 
routes and by direct extension. 
Bake? has detailed the reaction of the body tissues to invasion by B. 
dermatitidis. This response is essentially granulmatous, with varying combina- 
tions of suppuration, necrosis, and fibrosis. The t),pical microscopic picture is 
that of a tubercle-like lesion with epithelioid cells, plasma cells, lymphocytes, 
polymorphonuclear leukocytes, multinucleated giant cells, cellular debris, and 
the tissue forms of the organism itself. The proportion of the different cellular 
infiltrates to each other varies from case to case depending more upon the stage 
of the disease than the location of the lesion. In the more chronic cases, lympho- 
cJ.tic infiltration and fibrosis, showing attempts of healing, predominate; while 
in the more acute stage, where frank abscesses occur, the polvmorphonuclear 
leukocytes overwhelm the granulomatous infiltrate. The granuiomatous nature 
of the lesion may even be absent, as illustrated b,. the cases of primary inocu- 
lation cutaneous blastomycosis described by Wilson and his colleagues.52 His- 
topathologic sections of the skin lesions demonstrate a dense inflammatory in- 
filtrate of lymphocytes and polymorphonuclear leukocytes with numerous blas- 
tom>-cetes. The overlying epidermis in one of the cases was normal, in contrast 
to the pseudoepitheliomatous hyperplasia commonly observed in the other types 
of skin lesions. 
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The mimicry by North American blastomycosis of the tissue reactions of 
tuberculosis is SO close that many authors consider them indistinguishable 
on a morphologic basis alone. Several, 15*81 however, hold the presence of pyo- 
genie microabscesses and fibrosis as ground for strong suspicion and vigorous 
search for the casual organism. Caseation necrosis is not so frequent and char- 
acteristic as in tuberculosis. The identifying landmark in the histologic picture 
is the tissue form of the organism which may be seen scattered among the in- 
filtration cells, between the tissue cells, or in the giant cells. The number of 
organisms in a given lesion varies. The lesion may teem with the organisms 
or may show rare ones only after diligent examination of many sections. The 
organisms appear in histopathologic preparations as spherical or oval bodies 
ranging usually from 5 to 20 p in diameter. The cell walls are sharply delineated 
and thick, with a double-contoured appearance. The cytoplasm is granular 
and vacuolated. Single budding forms are often encountered, although in cer- 
tain instances they may be very difficult to demonstrate. The daughter bud 
usually rests on a broad base. 
Staining with the periodic acid-Schiff method of Hotchkiss and McManus 
is a valuable adjunct in the demonstration and study of the organisms in tissue 
sections.82,83 It is only supplementary, however, to cultural identification. 
The tissue forms of Blustomyces dermatitidis must be differentiated from 
those of the other systemic fungi, Histoplasma caps&turn, Coccidioides immitis, 
Blastomyces brasiliensis, Candida albicans, and Cryptococcus neoformans. His- 
toplasma capsulatum is distinguished by its smaller size of 2 to 5 /.L in diameter 
and intracytoplasmic location in the reticuloendothelial elements of the body. 
On the other hand, the nonbudding, endosporulating spherules of Coccidioides 
immitis, when mature, are much larger with a range of 20 to 80 /.L in diameter. 
Blastomyces brasiliensis is also larger, having diameters up to 60 p and charac- 
terized by multiple budding. The buds are connected by narrower processes 
and may be found all along the periphery of the mother cell. The budding yeast 
forms of Cundidu albicans are associated with filamentous pseudohyphae. Hyphal 
elements of Blastomyces dermatitidis have not been demonstrated in tissues. 
Cryptococcus neoformans possesses a remarkably thick capsule well seen in India 
ink preparations. 
The distinguishing features cited above are true for typical cases. How- 
ever, in certain instances differentiation may be very difficult. This is true with 
histoplasmosis when occasional miniature forms of Blastomyces dermatitidis13z84-88 
or giant forms of Histoplasma capsulatumsg do occur. The budding of Blas- 
tomyces dermatitidis may not be demonstrated, which may cause mistakes in 
diagnosis inasmuch as the nonbudding forms simulate the immature endospores 
of Coccidioides immitis of the same size. Blastomyces brasiliensis with single 
buds90 is easily mistaken for Blastomyces dermatitidis which, furthermore, may 
even rarely show multiple budding. Cryptococcus neoformans may occasionally 
be denuded of its thick capsule, depriving the examiner of this differentiating 
point. These different situations emphasize the essentiality of cultural pro- 
cedures in recognizing these fungi. 
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DlAGNOSIS 
As previously stated, there is no diagnostic pattern in the clinical histor) 
and manifestations of North American blastomycosis. Ejen the typical cutane- 
ous granuloma is only suggestive. Clinical diagnosis based on history and 
physical findings is, at most, presumptive and made unequivocal only by posi- 
tive demonstration and identification of the causative organism in the labora- 
tory. The procedures are neither elaborate nor expensive, and the only essen- 
tial requisite is familiarity with B. dermatitidis. 
Direct il~iicroscopic Examination.-The specimens examined with this pro- 
cedure are fresh, allegedly infected clinical materials such as pus, sputum, urine, 
cerebrospinal fluid, scrapings from skin lesions, prostatic fluid and effusions. 
The clinical means of obtaining these specimens, such as aspiration of subcu- 
taneous abscesses and of joints, spinal tap, prostatic massage, and collection of 
urine and sputum samples, are standard. Specimens from cutaneous lesions 
are best obtained by rupturing the small abscesses on the active borders and 
collecting the exuding purulent material. Weisel and Landis75 have recom- 
mended bronchoscopy as a diagnostic aid in pulmonary blastomycosis. Acree, 
Decamp, and Ochsnergl were able to establish the presence of an acute blasto- 
mycotic lung abscess by needle aspiration. 
Wet mounts of the specimens are prepared on slides with 10 per cent po- 
tassium hydroxide in order to “clear” the preparation. Spinal fluid, urine, and 
other less cellular specimens are mounted directly. These cover slip prepara- 
tions are examined under the microscope with subdued light. The organisms 
appear as previously described in stained sections, with the added feature of 
refractility of the thick, double-contoured walls. They may be difficult to finc:l 
and may be confused with other cellular elements, air bubbles, or oil droplets. 
Failure to demonstrate the organism by direct examination of fresh mounts does 
not necessarily rule out blastomycosis. 
Cultural Procedures.-Even when the tissue phase of B. dermatitidis is recog- 
nized in fresh or stained specimens, it is a wise policy to confirm this by isola- 
tion and identification of the organism in cultures. All specimens for labora- 
tory examination should be subjected to cultural procedures. Positive identi- 
fication of the organism by cultural means from suspected clinical specimens 
makes the clinical diagnosis practically indisputable in view of the rarity of 
isolating of B. dermatitidis from nature or from uninfected individuals. 
The specimens are planted on Sabouraud’s dextrose agar for incubation 
at room temperature and on blood agar or beef infusion dextrose agar at 37” C. 
The addition of streptomycin and penicillin to the media helps in keeping down 
bacterial contamination. When contaminants are present, subcultures of sus- 
picious colonies should be made to avoid overgrowth by the faster developing 
contaminants. The growth generally takes 10 days to 3 weeks to appear, but 
this period may be as brief as 3 days or may extend to 5 weeks, so that is it 
advisable to keep the cultures for at least 5 to 6 weeks before discarding. 
Blastomyces dermatitidis grows in its mycelial phase at room temperature. 
It develops as a white, cottony aerial growth or as a folded, membranous colon) 
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with spiny, coremial projections from the surface. The colonies tan with age. 
Microscopic examination reveals numerous round, oval or pyriform conidia 
measuring 3 to 5 microns in diameter and borne singly on short lateral sterigmas. 
These small spores are easily broken off from their attachments and are found 
lying free in wet mounts made from cultures. At 37” C. on blood agar or beef 
infusion dextrose agar, the growth is slower. The colonies are small, heaped up, 
waxy, and relatively easy to pick up from the surface of the agar. Microscopic 
examination reveals the single budding tissue phase, not infrequently associated, 
however, with short abortive hyphal filaments. The mycelial phase at room 
temperature and yeast phase at 37” C. are reversible, depending upon the tem- 
perature of incubation. This biphasic character of Blustomyces dermatitidis is 
valuable in its cultural differentiation from other pathogenic fungi, inasmuch as 
it automatically rules out organisms like Coccidioides immitis, Cryptoccoccus 
neoformans, and Cundida albicans, capable of growing only in one form in ordi- 
nary culture media. The other fungi which are biphasic in nature and easily 
confused with Blastomyces dermatitidis are Histoplasma capsulatum and Blas- 
tomyces brasiliensis. Hisloplasma capsulatum is differentiated by the production 
of tuberculate chlamydospores in its mycelial phase and the smaller size of the 
yeast forms. The distinguishing feature of Blastomyces brasiliensis is its mul- 
tiple budding at 37” C. Sporotrichum schenckii is also biphasic but the absence 
of cottony aerial growth and the black pigmentation of its mycelial colonies is 
characteristic together with the grouped disposition of its conidia. The yeast 
phase is small and may be cigar-shaped. 
Animal Inoculation.-The production of disease in laboratory animals by 
inoculation of suspected clinical materials or cultures is ordinarily not resorted 
to for diagnosis. When positive, it becomes a valuable diagnostic tool for it 
establishes not only the presence of the organism but also its virulence. The 
mouse has been found most suitable for this purpose. Intraperitoneal or intra- 
venous inoculation is followed by the appearance of suppurative nodular lesions 
in the liver, spleen, lungs, and lymph nodes. Rlaterial from these lesions as 
well as peritoneal washings show the typical J-eastlike tissue forms. 
Biopsy.-Kot too commonl>., suspicion of the presence of blastomycosis is 
first expressed by the histopathologist upon examination of surgically removed 
tissues for diagnosis and, or treatment of other conditions, such as tuberculosis 
or carcinoma. In a number of cases, the diagnosis is made only at the autops? 
table. Biopsy is a valuable diagnostic procedure, particularly if the biopsy ma- 
terial is cultured as well as sectioned. Skin biopsies are best taken from the typi- 
cal borders of the verrucous granulomas. Bronchoscopy, thoracotomy, pro- 
statectomy, and needle aspiration of the liver or lung have been utilized for 
biopsy purposes. 
Skin Test.-Cutaneous hypersensitiveness in a patient mith North American 
blastomycosis is demonstrated by a skin test using a vaccine of the killed yeast- 
phase organisms or a culture filtrate called Blastomycin. The Blastomycin 
skin test is akin to tuberculin with a similar technique of performance, reading, 
and significance. The intradermal injections of 0.1 ml. of standardized antigen 
in dilutions of 1:lO to l:lOO,OOO, depending upon the degree of sensitivity, re- 
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sults in the appearance of maximal erythema with central induration in 24 to 
48 hours. III very sensitive individuals, if the more concentrated antigen is 
used, a sterile abscess may develop.9” In the average patient, it is customary 
to start with a l:l,OOO dilution of the commercially available Blastomycin. 
A positive Blastomycin skin test generally- indicates a past or present infec- 
tion. A-Uthough only presumptive diagnostic evidence, the test is particularI>, 
helpful in mild or obscure cases or in cases where materials for biopsy or culture 
are not easil). accessible. Its full significance, however, has not been established 
as ?-et because of the lack of opportunities to investigate the disease in large series, 
in contrast to the frequent sizable skin test surveys on tuberculosis, coccidioi- 
domycosis, and histoplasmosis. The results obtained with Blastomycin skin 
test are not as constant as those of the latter three diseases. The test is negative 
in the earl). stages of the disease, in mild localized cutaneous cases, and in the 
over\vhelming or terminal phases when anerg>- occurs. Disturbing results were 
reported by Smithj6 in the form of negative results in at least 25 per cent oi 
patients with early proved blastomycosis and positive skin tests in 3 health)~ 
medical students and 10 patients \I-ith no evidence of active disease. .&I impor- 
tant misleading factor is the occurrence of cross reactions with Histoplasmin 
ant1 (‘oc-cidioiding3 and the antigen of Blastomyces brasiliensis,g~ apparentI)- due 
to a common antigen. Cross reactions between Histoplasmin and Blastomycin 
are frequent. Patients with histoplasmosis may even give larger Blastomycin 
skin reactions than patients with proved blastom>,cosis. Mistakes arising from 
these cross reactions are obviated, however, if the Coccidioidin, Histoplasmin. 
and BlastomJ.cin skin tests are performed simultaneously on all patients sus- 
pected of these mycotic infections, inasmuch as the skin reactions to the homol- 
ogous antigens are significantly larger. 
Complement Fixation Tats.-The sera of putiellts with blastom>*cosis are 
able to fix complement with suspensions or extracts of B. dermatitidis as anti- 
gens.gj,Y6 Like ;I positive Blastomycin skin test, a positive complement fixation 
test is only- presumptive, but it has been found useful in detecting cases alld 
spurring greater efforts aimed at more definitive diagnosis by demonstration of 
the organism through mycologic or histopathologic stuclies. The complement. 
fixing titer is generalI>- zero or low in early, mild, or subclinical infection or in 
well-localized cutaneous disease. Two of the 4 cases of primaq- inoculation 
cutaneous blastomycosis followed by R’ilson and associatess? had no or slighti). 
detectable complement-fixing antibodies. The titer increases with progression 
of the disease and remains high through the terminal stages.Y7,YH In our experi- 
ence a negative Blastomycin skin test and high complement fixation test signify 
a poor prognosis. With the recover?. of the patient, the antibodies gradualI> 
disappear from circulation. The passive transfer of these antibodies from mother 
to child has been demonstrated bsr Noojin and Praytor.66 
Unfortunately, sera from patients with histoplasmosis, coccidioidomycosis, 
or blastomycosis, both Sorth and South American, cross react.93~g8-1uZ The major 
cross-over occurs between histoplasmosis and blastom>.cosis. It is desirable to 
perform the complement fixation tests simultaneousI\, with the 3 types of anti- 
gens, for the homologous serum generally shows ;1 higher titer. 
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Other serologic tests like the precipitin and collodion agglutination tests 
have not gained general acceptance. The interpretation of their results is more 
difficult. 
DIFFERENTIAL DIAGNOSIS 
Because of the protean nature of its manifestations, North American blas- 
tomycosis is easily confused with many other conditions. Misdiagnosed cases 
have reached the autopsy table before the organisms were accidentally discov- 
ered. The differential diagnosis depends upon the presenting signs and symp- 
toms of the organ or organs most extensively involved. 
The cutaneous lesions are mistaken for tuberculosis verrucosa cutis, lupus 
vulgaris, nodulo-ulcerative syphilid, gumma, squamous and basal cell carcinoma, 
mycosis fungoides, iododerma, sporotrichosis, coccidioidal and paracoccidioidal 
granulomas, chromoblastomycosis, actinomycosis, cryptococosis, trichophytic 
granuloma, granuloma inguinale, anthrax, tularemia, pyoderma vegetans, yaws, 
and cutaneous leishmaniasis. The primary inoculation type of cutaneous blas- 
tomycosis is to be differentiated from other chancriform diseases such as primary 
inoculation tuberculosis, sporotrichosis, tularemia, syphilis, yaws, American leish- 
maniasis, and cat-scratch fever. 
The respiratory symptoms associated with the usual onset of systemic 
(pulmonary) North American blastomycosis simulate the common cold, influ- 
enza, or pneumonia. The differential considerations in the more developed sys- 
temic disease are tuberculosis, syphilis, primary and metastatic malignancies, 
pulmonary abscess, pneumonias, sarcoid, lymphoblastoma, pneumoconiosis, mul- 
tiple myeloma, tularemia, pyemia, osteomyelitis, psoas abscess, histoplasmosis, 
coccidioidomycosis, South American blastomycosis, sporotrichosis, cryptococcosis, 
candidiasis, and actinomycosis. 
In making the differential diagnosis of blastomycosis, the possibility that it 
may occur simultaneously in the same patient with other disease such as tuber- 
culosis,103~104 carcinoma,lo5*lo6 sarcoidosis,lo7 and histoplasmosis*7 must be borne in 
mind. 
PROGNOSIS 
In untreated cases, the prognosis of the classical cutaneous blastomycosis 
is good as regards life expectancy, but its chronic recurrent course extends through 
many years. The risk of conversion into the graver systemic form is ever pres- 
ent, but fortunately rarely occurs. No definite conclusion was drawn by Wilson 
and his colleagues52 as regards the prognosis of the cases of primary inoculation 
type of cutaneous blastomycosis they described, but they were inclined to be- 
lieve that this form tends to heal spontaneouslv. 
The systemic disease, with involvement of visceral organs, has a fore- 
boding prognosis. Its high fatality rate has been accepted by many on the 
strength of previous clinical reports. Recently, however, conflicting data have 
been reported. Kunkel and associatesr5 recorded 7 deaths among 2.5 proved 
and presumptive cases and the series of 18 cases reported by Sutliff, Kyle, and 
Hobson16 included only 2 deaths. The contention that subclinical and/or spon- 
taneously healing North American blastomycosis exists remains to be confirmed 
in larger numbers of patients. 
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In the evaluation of prognosis, much help can be obtained from a study of 
the immunologic picture of the patient. As early as 1939, Martin and Smiths 
suggested the use of the complement fixation titer of the serum as a measure of 
the extent of infection and the negative skin test as in indication of anergy brought 
about by extensive, overwhelming disease. In subsequent papers,g7J08~109 they 
confirmed the value of the complement fixation test and the cutaneous test in 
prognostication. A favorable outcome is generally expected in patients with 
a negative complement fixation test and a positive skin test. On the other hand, 
a high titer of complement-fixing antibodies and a negative skin reaction usually 
means a grave prognosis. 
TREhTMENT 
The treatment of North American bIastom>-cosis, especially the sJ,stemic 
form, has been unsatisfactory, as evidenced by the multitude of therapeutic 
modalities used to control the disease. Recently, however, the emergence of a 
number of promising chemotherapeutic agents is changing the dismal picture. 
Cutaneous Blastomycosis.-Skin lesions may undergo complete regression 
with apparent cure under treatment but the clinical improvement is often only 
temporary and recurrences are frequent, especially after cessation of therapy. 
Since its first use by Gilchrist, iodide therapy has been most extensively 
used, with some success. Iodides are given in the form of a saturated solution 
of potassium iodide orally or of sodium iodide intravenously. AndrewsIlO found 
that a mixture of equal parts of ammonium, sodium, and potassium iodides is 
better tolerated than potassium iodide alone. The importance of determining 
the cutaneous hypersensitiveness of the patient by skin testing before instituting 
treatment, especially with iodides, has been repeatedly emphasized in the litera- 
ture. This is to avoid untoward reactions, and even fatal dissemination, which 
may occur when a patient with a strongly positive skin test is given idoides. 
When a positive skin test is obtained, reduction of the cutaneous hypersensiti- 
vit?, of the patient is strongly advised by means of hyposensitization with vaccine 
before treatment is initiated. Vaccine has also been utilized therapeutically by 
some authors with variable results. The technical details of iodide therapy and 
hyposensitization by vaccine are amply described by Conant and co-workers.“’ 
Surgical procedures are also of some value in certain types of the disease. 
Complete excision with or without skin grafting can be done on the smaller, 
localized lesions. Cauterization, electrocoagulation, cryotherapy or curettage 
has been combined with iodide therapy and roentgenotherapy, but the greater 
risk of dissemination accompanying these procedures has been admitted. 
Roentgen therapy is another noteworthy therapeutic aid. It has been used 
to eradicate small, early lesions ‘12, but is generally combined with iodides and 
minor surgical procedures. The usual dose given is 75 to 100 roentgen units 
through 1 to 2 mm. Al once a week for 10 to 14 weeks.110b113 
The best results are admittedly obtained through combination of iodide 
therapq-, surgical procedures, roentgen therap?, and vaccine hyposensitization. 
Lesions that are recalcitrant to the above regimes should be treated with the 
newer chemotherapeutic agents. Local application of silver nitrate, bichloride 
of mercury, copper sulfate, phenol, and gentian violet are not generally accepted. 
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Systemic Blastomycosis.-Before the advent of the aromatic diamidines, 
iodide therapy was the recommended treatment. Its use, however, is empirical 
and although temporary improvement, and even cure, may occur, it does not 
essentially alter the course of the disease. It may even affect the disease ad- 
versely. Previously, it was widely employed because of the lack of any more effica- 
cious treatment. The reports of successful treatment with the following agents 
are mainly unconfirmed: undecylenic acid,sO,l’d Aureomycin,1*5 colloidal copper 
sulfate,116 ether, I17 and penicillin.118 
The most revolutionary development in the treatment of ,North American 
blastomycosis was the introduction of the aromatic diamidines. A few members 
of this group of chemical compounds had been in use for the treatment of try- 
panosomiasis and leishmaniasis at the time Elsonng reported the in vitro effec- 
tiveness of Propamidine against B. dermatitidis. The knowledge gained from the 
clinical experience with the use of the drugs on these tropical diseases was applied 
with facility to the treatment of North American blastomycosis. The first 
attempt to use an aromatic diamidine to control this disease was made in 1950 
by Colbert, Strauss, and Green*?* with Propamidine. Stilbamidine was first 
used with success by Schoenbach and associates’“’ the next Irear although Cherniss 
and WaisbrenlB recently claimed the fortuituous treatment with stilbamidine of 
a patient with systemic blastomycosis misdiagnosed as multiple myeloma in 
1948. This first report by Schoenbach and his associates was followed by num- 
erous descriptions of clinical experiences on the use of stilbamidine and its closely 
allied compound, 2-hydroxystilbamidine, in the treatment of North American 
blastomycosis. 15~‘6~1~~26~40~103~104~122-244 These accumulating experiences testify to 
the clinical efficacy of these drugs. It is true that remarkable improvement and 
apparent cures have been attained in a significant number of cases with their 
use, but they do not control the disease in all cases. Treatment failures, espe- 
cially in the form of recurrences, have been recorded as more cases are treated 
and observed for longer periods (Fig. 9). 
The pharmacology and mode of administration of stilbamidine and 2- 
hydroxystilbamidine have been exhaustively reviewed123.‘?4,131,132,145,146 elsewhere. 
Further observations of the posttherapeutic course of the cases of blastomycosis 
treated in the University of Michigan Medical Center with the aromatic di- 
amidines has been described in a previous paper.14? Table I summarizes the 
salient features of the poststilbamidine periods in 6 patients. The longest period 
a patient was observed after the institution of treatment was 4 years and 9 
months. The total doses received by Case 2 of 22.5 Gm. of stilbamidine and 
21.3 Gm. of 2_hydroxystilbamidine, by Case 5 of 17.8 Gm. of stilbamidine, and 
by Case 6 of 18.2 Cm. of 2-hydroxystilbamidine certainly are massive in com- 
parison to the average recommended dosages of 3 to 5 Gm. of stilbamidine and 
9 to 12 gm. of 2-hydroxystilbamidine. The optimum dosages and mode of ad- 
ministration of these drugs remain to be determined. In the more recent treat- 
ment courses given to these patients, the individual doses were increased to 300 
mg. stilbamidine and/or 450 mg. of 2-hydroxystilbamidine without any unto- 
ward reactions. The relapses in 4 of the 6 patients underscore the occurrence 
of treatment failures in spite of the relatively huge doses given in futile attempts 
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to control the disease. The appearance of toxic neuropathy in the same number 
of patients constitutes another complication of the drug stilbamidine which is 
claimed to be avoided by the use of the more stable, less toxic but also less effec- 
tive 2-hydroxystilbamidine. Toxic neuropathy has appeared in 50 to 60 per cent 
of the reported cases of North American blastomycosis under Stilbamidine ther- 
ap!’ and does not seem to be related entirely to the total amount administered. 
The occurrence of therapeutic relapses and toxic reactions detract from the 
clinical value of the diamidines in the treatment of blastomycosis. The final 
answer to the search for the ideal chemotherapeutic agent in the treatment of 
North American blastomycosis may yet come from the growing list of anti- 
fungal antibiotics such as Rimocidin, Fradicin, Mycostatin, and Atnphotericin 
which ma)- parallel the achievements of penicillin, Terramycin, streptomycin, 
and other antibacterial antibiotics in microbial infections. 
Fig. Q.-G. G. (Table I) now has had more than 22.5 Gm. of stilbamidine and more than 21.3 Cm. 
of 2-hydroxystilbamidine (he is now under hospital treatment for a relapsing disease). Although his 
organism has shown increasing tolerance to the drugs, he still can be controlled by larger doses and pro- 
longed treatment. (Prom Curtis and Harrell, A. M. A. Arch. Dermat. & Syph. 66x376, 1952.) 
Surgical procedures are of certain value in systemic blastomycosis. Incision 
and drainage of large pockets of pus is recommended. Urinary obstruction due 
to prostatic involvement requires surgery. Excision of laryngeal,147J4R prostatic, 
and uterine6” lesions has been attempted. Levitas and Baum’4g regard it worth 
while to excise isolated, metastatic lesions of the skin or peripheral bones with 
the possibility of an arrest of the primary focus in the lungs. Even if the vis- 
ceral lesions remain active, they still suggest extirpation of skin lesions by reason 
of avoiding cosmetic deformities and eradicating these lesions as foci of further 
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With greater use of stilbamidine and an acceptance of the concept of the 
lung being the primary focus, interest in the value of lung resection in the treat- 
ment of pulmonary blastomycosis has increased. 15.22.40.80~91,114,136,149-161 Excisional 
surgery appears reasonably indicated in the few instances where a localized pul- 
monary focus exists without evidence of dissemination. The usual pulmonary 
lesions when discovered, however, are often diffuse and do not lend themselves 
to surgical treatment or may be associated with other visceral foci. Management 
of pulmonary blastomycosis today is comparable to that of pulmonary tuber- 
culosis where surgical intervention has become a valuable adjunct to chemother- 
apy. In a like manner, pulmonary resection in blastomycosis is reserved for 
the residual, irreparably damaged tissues after diamidine therapy. In instances 
of required diagnostic thoracotomy or therapeutic surgery of misdiagnosed pul- 
monary lesions, postoperative courses of diamidines are indicated. 
Supportive general measures for the blastomycotic patient, such as bed rest 
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